Cash flows from operating activities: | |
Net income | 327.24M |
Adjustments to reconcile net income to net cash provided by operating activities: | |
Depreciation | 22.81M |
Amortization | 7.71M |
Stock-based compensation | 59.21M |
Net gain on sale of available-for-sale securities | -823K |
Amortization of debt discount on convertible debentures | 6.03M |
Derivatives - revaluation and amortization | |
Tax benefit from exercise of stock options | |
Excess tax benefit from stock-based compensation | |
Changes in assets and liabilities: | |
Accounts receivable, net | 79.7M |
Inventories | -18.41M |
Deferred income taxes | |
Prepaid expenses and other current assets | -3.77M |
Other assets | -5.04M |
Accounts payable | 1.7M |
Accrued liabilities | 19.05M |
Income taxes payable | -11.44M |
Deferred income on shipments to distributors | 5.65M |
Net cash provided by operating activities | 522.23M |
Cash flows from investing activities: | |
Purchases of available-for-sale securities | -1.95B |
Proceeds from sale and maturity of available-for-sale securities | 2.02B |
Purchases of property, plant and equipment | -31.95M |
Other investing activities | -15.85M |
Net cash used in investing activities | 22.55M |
Cash flows from financing activities: | |
Repurchases of common stock | -200.14M |
Proceeds from issuance of common stock through various stock plans | |
Payment of dividends to stockholders | -167.48M |
Proceeds from issuance of convertible debts, net of issuance costs | |
Purchase of call options | |
Proceeds from issuance of warrants | |
Excess tax benefit from stock-based compensation | |
Net cash provided by (used in) financing activities | -358.1M |
Net decrease in cash and cash equivalents | 186.67M |
Cash and cash equivalents at beginning of period | 503.82M |
Cash and cash equivalents at end of period | 690.49M |
Supplemental disclosure of cash flow information: | |
Interest paid | 20.69M |
Income taxes paid, net of refunds | 9.12M |